腦生物標記市場：按產品、適應症、最終用戶和用途- 全球預測 2023-2030

預計到 2023 年，全球腦生物標記市場將達到 8,94,724 萬美元，年複合成長率為 17.88%，預計到 2030 年將實現驚人成長，達到 2833,738 萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球大腦生物標記市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.腦生物標記的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球腦生物標記市場的阻礙因素和影響為何？

3.在預測期內，全球腦生物標記市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球腦生物標記市場的競爭策略是什麼？

5. 全球腦生物標記市場的技術趨勢和法律規範是什麼？

6.全球腦生物標記市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球腦生物標記市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 研發投資旨在提高對神經系統疾病的了解並治療越來越多患有腦部疾病的老年人
    • 需要侵入性大腦品嚐、有效的藥物開發、更快的診斷和新的治療選擇
    • 檢測和解釋以支持臨床決策和患者干涉
  • 抑制因素
    • 缺乏消費者意識
  • 機會
    • 不斷發展的生物標記資料管理平台，支援基於生物標記的藥物開發和轉化研究
    • 將可檢測參數涵蓋大腦生物標記以改善臨床決策
  • 任務
    • 巨大的生物異質性加劇了發炎的複雜性
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化
  • 產品開發平臺

第6章 生物標記市場：副產品

• 生物標記分析儀
• 生物標記檢測套組

第7章 生物標記市場

• 阿茲海默氏症
• 亨丁頓舞蹈症
• MND 和 ALS
• 帕金森氏症
• 中風

第8章 生物標記市場：依最終用戶分類

• 門診手術中心
• 診斷實驗室
• 醫院
• 調查

第9章 生物標記市場：依用途

• 診斷
• 藥物研發發現與開發

第10章 美洲腦生物標記市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第11章亞太腦生物標記市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第12章歐洲、中東和非洲腦生物標記市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第13章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第14章上市公司名單

第15章附錄

• 討論指南
• 關於許可證和定價

The Global Brain Biomarkers Market is forecasted to grow significantly, with a projected USD 8,947.24 million in 2023 at a CAGR of 17.88% and expected to reach a staggering USD 28,337.38 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Brain Biomarkers Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Brain Biomarkers Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Biomarker Analyzers and Biomarker Test Kits. The Biomarker Analyzers is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Alzheimer's Disease, Huntington's Disease, MND & ALS, Parkinson's Disease, and Stroke. The Parkinson's Disease is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, and Research Laboratories. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Application, market is studied across Diagnosis and Drug Discovery & Development. The Diagnosis is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Brain Biomarkers Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Brain Biomarkers Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Brain Biomarkers Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Brain Biomarkers Market?

4. What is the competitive strategic window for opportunities in the Global Brain Biomarkers Market?

5. What are the technology trends and regulatory frameworks in the Global Brain Biomarkers Market?

6. What is the market share of the leading vendors in the Global Brain Biomarkers Market?

7. What modes and strategic moves are considered suitable for entering the Global Brain Biomarkers Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Brain Biomarkers Market, by Product, 2022 vs 2030
• 4.3. Brain Biomarkers Market, by Indication, 2022 vs 2030
• 4.4. Brain Biomarkers Market, by End-Users, 2022 vs 2030
• 4.5. Brain Biomarkers Market, by Application, 2022 vs 2030
• 4.6. Brain Biomarkers Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Improved knowledge of neurologic diseases and R&D investment to treat growing geriatric population with brain disorder
    • 5.1.1.2. Need for invasive brain tastings, effective drug development, faster diagnosis, and new treatment option
    • 5.1.1.3. Detection and interpretation to support clinical decisions and patient interventions
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of consumer awareness
  • 5.1.3. Opportunities
    • 5.1.3.1. Evolving biomarker data management platforms to support biomarker-guided drug development and translational research
    • 5.1.3.2. Incorporation of detectable parameters with brain biomarkers to improve clinical decision making
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity of neuroinflammation exacerbated by substantial biological heterogeneity
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization
  • 5.9.1. Product Development Pipeline

6. Brain Biomarkers Market, by Product

• 6.1. Introduction
• 6.2. Biomarker Analyzers
• 6.3. Biomarker Test Kits

7. Brain Biomarkers Market, by Indication

• 7.1. Introduction
• 7.2. Alzheimer's Disease
• 7.3. Huntington's Disease
• 7.4. MND & ALS
• 7.5. Parkinson's Disease
• 7.6. Stroke

8. Brain Biomarkers Market, by End-Users

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Diagnostic Laboratories
• 8.4. Hospitals
• 8.5. Research Laboratories

9. Brain Biomarkers Market, by Application

• 9.1. Introduction
• 9.2. Diagnosis
• 9.3. Drug Discovery & Development

10. Americas Brain Biomarkers Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Brain Biomarkers Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Brain Biomarkers Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BRAIN BIOMARKERS MARKET RESEARCH PROCESS
• FIGURE 2. BRAIN BIOMARKERS MARKET SIZE, 2022 VS 2030
• FIGURE 3. BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
• FIGURE 6. BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
• FIGURE 7. BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. BRAIN BIOMARKERS MARKET DYNAMICS
• FIGURE 10. BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BRAIN BIOMARKERS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMER'S DISEASE , BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BRAIN BIOMARKERS MARKET SIZE, BY HUNTINGTON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BRAIN BIOMARKERS MARKET SIZE, BY MND & ALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BRAIN BIOMARKERS MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 14. BRAIN BIOMARKERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BRAIN BIOMARKERS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. CANADA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. CHINA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 59. CHINA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 63. INDIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. ITALY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 132. ITALY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. POLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 148. POLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. QATAR BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 152. QATAR BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 190. BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 191. BRAIN BIOMARKERS MARKET LICENSE & PRICING